---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-204425"
form_type: "8-K"
ticker: "RNTX"
cik: "0001420565"
company_name: "Rein Therapeutics, Inc."
filed_at: "2024-08-21T23:59:59+00:00"
generated_at: "2026-05-31T08:13:00.834647+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Aileron Therapeutics 2024 annual meeting: re-elects directors, ratifies auditor

## Summary
- Re-elected Brian Windsor, Ph.D. and Alan A. Musso as Class I directors (7.8M for, ~24k withheld each, 3.4M broker non-votes).
- Advisory vote on named executive officer compensation passed: 7.3M for, 109k against, 416k abstain.
- Ratified Marcum LLP as independent auditor for FY 2024: 10.8M for, 61k against, 416k abstain.

## SEC filing metadata
- accession: 0001193125-24-204425
- form_type: 8-K
- ticker: RNTX
- cik: 0001420565
- company_name: Rein Therapeutics, Inc.
- filed_at: 2024-08-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420565/000119312524204425/0001193125-24-204425-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420565/000119312524204425/d862681d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-204425
- JSON: https://secwatch.observer/filing/0001193125-24-204425.json
- Plain text: https://secwatch.observer/filing/0001193125-24-204425.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.